Biopsy Needle Market Players:
- Argon Medical Devices Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton
- Cardinal Health
- Olympus Corporation
- Argon Medical Devices Inc
- Devicor Medical Products, Inc
- B. Braun Melsungen AG
- Cook Group Incorporated
- FUJIFILM Holdings Corporation
- Dickinson and Company
- Stryker Corporation
- INRAD, Inc.
The biopsy needle market is highly competitive, consisting of key players operating at global and regional levels. The key players are focused on developing advanced tools and products to cater to the rising demand for effective diagnostic tools. These key players are also adopting several strategies such as joint ventures, acquisitions, and product launches to sustain their market position and enhance their product base. Here’s a list of key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of biopsy needle is estimated at USD 1.42 billion.
The global biopsy needle market size was more than USD 1.34 billion in 2025 and is anticipated to grow at a CAGR of over 6.7%, reaching USD 2.56 billion revenue by 2035.
North America’s biopsy needle market will account for 41.2% share by 2035, driven by strong healthcare infrastructure and medical R&D.
Key players in the market include Becton, Medtronic Plc, Cardinal Health, Hologic Inc., Olympus Corporation, Argon Medical Devices Inc., Devicor Medical Products, Inc., Cook Group Incorporated, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson and Company, and INRAD, Inc.
